Redefining prognostic factors for breast cancer: YB-1 is a stronger predictor of relapse and disease-specific survival than estrogen receptor or HER-2 across all tumor subtypes

Last 30 days: 186 accesses
Last 365 days: 1982 accesses
All time: 9409 accesses

Golareh Habibi, Samuel Leung, Jennifer H Law, Karen Gelmon, Hamid Masoudi, Dmitry Turbin, Michael Pollak, Torsten O Nielsen, David Huntsman and Sandra E Dunn^*